1. Multimodal theranostic assemblies: double encapsulation of protoporphyrine-IX/Gd3+in niosomes
   F. Baris Barlas et al, 2016, RSC Advances CrossRef
2. Photosensitizer and Radio-Dynamic Therapy (RDT)
   Junkoh Yamamoto et al, 2021, Nippon Laser Igakkaishi CrossRef
3. Combination of rehydrated whey protein isolate aqueous solution with blackcurrant concentrate and the formation of encapsulates via spray-drying and freeze-drying: Alterations to the functional properties of protein and their anticancer properties
   Gang Wu et al, 2021, Food Chemistry CrossRef
4. The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review
   Niklas Benedikt Pepper et al, 2022, Strahlentherapie und Onkologie CrossRef
5. Natural and synthetic compounds for glioma treatment based on ROS-mediated strategy
   Yu-Fei Wang et al, 2023, European Journal of Pharmacology CrossRef
6. Reactive Oxygen Species Produced by 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Cancer
   Pamela Pignatelli et al, 2023, International Journal of Molecular Sciences CrossRef
7. 5-Aminolevulinic acid enhances mitochondrial stress upon ionizing irradiation exposure and increases delayed production of reactive oxygen species and cell death in glioma cells
   Kunihiro Ueta et al, 2017, International Journal of Molecular Medicine CrossRef
8. Commentary: The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas
   Deepak Khatri et al, 2020, Neurosurgery CrossRef
9. Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms
   Shiyu Liu et al, 2022, Frontiers in Pharmacology CrossRef
10. Characterization and application of targeted MnO2/CS@ALA-MTX nano-radiosensitizers for boosting X-ray radiotherapy of brain tumors
    Yasin Ayyami et al, 2024, Colloids and Surfaces A: Physicochemical and Engineering Aspects CrossRef
11. Radiosensitizing effect of 5‑aminolevulinic acid in colorectal cancer in�vitro and in�vivo
    Kazuto Yamada et al, 2019, Oncology Letters CrossRef
12. Therapeutic effects of in-vivo radiodynamic therapy (RDT) for lung cancer treatment: a combination of 15MV photons and 5-aminolevulinic acid (5-ALA)
    Dae-Myoung Yang et al, 2022, Biomedical Physics & Engineering Express CrossRef
13. 5-Aminolevulinic acid radiodynamic therapy for treatment of high-grade gliomas: A systematic review
    Nathan J. Nordmann et al, 2021, Clinical Neurology and Neurosurgery CrossRef
14. Intracellular reactive oxygen species level in blood cells of atomic bomb survivors is increased due to aging and radiation exposure
    Tomonori Hayashi et al, 2021, Free Radical Biology and Medicine CrossRef
15. A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen
    Richard E. Kast et al, 2020, Brain Sciences CrossRef
16. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy
    Junko Takahashi et al, 2021, International Journal of Molecular Sciences CrossRef
17. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma
    Niklas Benedikt Pepper et al, 2024, Radiation Oncology CrossRef
18. 5‑aminiolevulinic acid induces a radiodynamic effect with enhanced delayed reactive oxygen species production under hypoxic conditions in lymphoma cells: An in vitro study
    Kohei Suzuki et al, 2023, Experimental and Therapeutic Medicine CrossRef
19. Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid–Guided Surgery: A Systematic Review and Meta-Analysis
    Sirin Gandhi et al, 2019, Frontiers in Oncology CrossRef
20. Combining Doxorubicin-Conjugated Polymeric Nanoparticles and 5-Aminolevulinic Acid for Enhancing Radiotherapy against Lung Cancer
    Jinghua Han et al, 2022, Bioconjugate Chemistry CrossRef